Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:04 PM
Ignite Modification Date:
2025-12-26 @ 4:04 PM
NCT ID:
NCT00810706
Eligibility Criteria:
Inclusion Criteria:
* postmenopausal women only
* histologically confirmed stage I-IIIA primary adenocarcinoma of the breast
* estrogen and/or progesterone receptors positive or unknown
* patients should have undergone surgery with a curative intent
* patients must have completed at least 5 years and not more than 7 years of continued treatment with tamoxifen (20 mg/day), while tamoxifen could have been discontinued up to 6 months prior to study entry
* Absence of any evidence of local or distant metastatic disease was required prior to randomization
Exclusion Criteria:
* DCIS, bilateral breast cancer, evidence of metastasis, ER and Pgr negative
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00810706
Study Brief:
Protocol Section:
NCT00810706